3,4-methylenedioxyamphetamine has been researched along with reserpine in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 7 (77.78) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fadayel, GM; Schmidt, CJ; Sullivan, CK; Taylor, VL | 1 |
Ali, SF; Chang, LW; Slikker, W | 1 |
Conarty, PF; Johnson, MP; Nichols, DE | 1 |
Black, CK; Schmidt, CJ; Taylor, VL | 1 |
Hekmatpanah, CR; McKenna, DJ; Peroutka, SJ | 1 |
Gibb, JW; Hanson, GR; Johnson, M; Stone, DM | 1 |
Rudnick, G; Schuldiner, S; Steiner-Mordoch, S; Wall, SC; Yelin, R | 1 |
Fitzgerald, JL; Reid, JJ | 1 |
Azmitia, EC; Gu, XF | 1 |
1 review(s) available for 3,4-methylenedioxyamphetamine and reserpine
Article | Year |
---|---|
Biogenic amines as biomarkers for neurotoxicity.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Biogenic Amines; Biomarkers; Female; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System; Reserpine | 1991 |
8 other study(ies) available for 3,4-methylenedioxyamphetamine and reserpine
Article | Year |
---|---|
5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Animals; Brain Chemistry; Dialysis; Dopamine; Fluorobenzenes; Haloperidol; Homovanillic Acid; Male; N-Methyl-3,4-methylenedioxyamphetamine; Piperidines; Rats; Rats, Sprague-Dawley; Reserpine; Serotonin Antagonists | 1992 |
[3H]monoamine releasing and uptake inhibition properties of 3,4-methylenedioxymethamphetamine and p-chloroamphetamine analogues.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Designer Drugs; Dopamine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; Norepinephrine; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Regression Analysis; Reserpine; Serotonin; Synaptosomes | 1991 |
Antagonism of the neurotoxicity due to a single administration of methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Biogenic Monoamines; Brain; Catecholamines; Hydroxydopamines; Indoles; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nervous System Diseases; Oxidopamine; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Reserpine; Serotonin; Substantia Nigra; Tryptophan Hydroxylase | 1990 |
Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced neurotoxicity in the rat.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Cerebral Cortex; Corpus Striatum; Designer Drugs; Dopamine; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Endings; Nervous System Diseases; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Reserpine; Serotonin | 1989 |
Role of endogenous dopamine in the central serotonergic deficits induced by 3,4-methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; alpha-Methyltyrosine; Amphetamines; Animals; Brain; Dopamine; Hydroxydopamines; Male; Methyltyrosines; N-Methyl-3,4-methylenedioxyamphetamine; Oxidation-Reduction; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Serotonin; Reserpine; Serotonin; Tryptophan Hydroxylase | 1988 |
Amphetamine derivatives interact with both plasma membrane and secretory vesicle biogenic amine transporters.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Blood Platelets; Carrier Proteins; Cattle; Cell Membrane; Chromaffin Granules; Fenfluramine; Humans; In Vitro Techniques; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; p-Chloroamphetamine; Reserpine; Serotonin; Serotonin Plasma Membrane Transport Proteins | 1993 |
Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamine; Animals; Biogenic Monoamines; Brain; Calcium; Electric Stimulation; Female; In Vitro Techniques; Male; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; Pargyline; Rats; Rats, Sprague-Dawley; Reserpine | 1993 |
Integrative transporter-mediated release from cytoplasmic and vesicular 5-hydroxytryptamine stores in cultured neurons.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain Stem; Carrier Proteins; Cells, Cultured; Clorgyline; Female; Fluoxetine; Membrane Glycoproteins; Membrane Transport Proteins; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neurons; Nimodipine; p-Chloroamphetamine; Pregnancy; Rats; Rats, Sprague-Dawley; Reserpine; Selegiline; Serotonin; Serotonin Plasma Membrane Transport Proteins | 1993 |